Versant Capital Management »

Sage Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.5k 346 7.22
2024-06-30 $945 87 10.86
2024-03-31 $561 30 18.73
2023-12-31 $650 30 21.67
2023-09-30 $165 8 20.63
2023-06-30 $705 15 47.00

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Ishares S&p Global Energy Etf (IXC)
Microsoft Stock (MSFT)
Vaneck Gold Miners Etf Etf (GDX)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vanguard Total Stk Mkt Etf (VTI)
Exxon Mobil Corp Stock (XOM)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Spdr Gold Minishares Trust Etf (GLDM)
Dimensional Us Marketwide Value Etf Etf (DFUV)

View all positions for Versant Capital Management

Top funds holding Sage Therapeutics

Vanguard Group
BlackRock
BlackRock
Bellevue Group
State Street Corporation
Morgan Stanley
Jacobs Levy Equity Management
Geode Capital Management
Palo Alto Investors
Acadian Asset Management
Goldman Sachs Group
Citadel Advisors
D. E. Shaw & Co
Federated Investors
Bank of America Corporation

View all funds holding Sage Therapeutics